DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
AZD7325
2
Small molecule
Investigational
Unknown
Unknown
Fragile X Syndrome; Anxiety; Child Development Disorders, Pervasive
GABA receptor alpha-2 subunit positive allosteric modulator
AZD7325
×
Maximum Phase:
2
First Approval:
None
UNII:
KNM216XOUH
Molecule Type:
Small molecule
Molecular Formula:
C19H19FN4O2
Molecular Weight:
354.39
AlogP:
3.17
PSA:
90.13
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ADRIFORANT
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Dermatitis; Dermatitis, Atopic; Psoriasis
Histamine H4 receptor antagonist
ADRIFORANT
×
Maximum Phase:
2
First Approval:
None
UNII:
D65H9YE9VU
Molecule Type:
Small molecule
Molecular Formula:
C13H22N6
Molecular Weight:
262.36
AlogP:
0.68
PSA:
79.1
HBD:
3.0
HBA:
#RotB:
5.0
Source:
VAPITADINE DIHYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Histamine H1 receptor antagonist
VAPITADINE DIHYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
R612XR8A9F
Molecule Type:
Small molecule
Molecular Formula:
C17H22Cl2N4O
Molecular Weight:
369.3
AlogP:
1.21
PSA:
72.94
HBD:
2.0
HBA:
#RotB:
1.0
Source:
IBERDOMIDE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Lupus Erythematosus, Systemic; Sarcoidosis; Smoldering Multiple Myeloma
Unknown
IBERDOMIDE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
79L3645KFI
Molecule Type:
Small molecule
Molecular Formula:
C25H28ClN3O5
Molecular Weight:
485.97
AlogP:
1.86
PSA:
88.18
HBD:
1.0
HBA:
#RotB:
6.0
Source:
QLT0074
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
QLT0074
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UR-63325
2
Small molecule
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal
Histamine H4 receptor antagonist
UR-63325
×
Maximum Phase:
2
First Approval:
None
UNII:
B61N8R7TDH
Molecule Type:
Small molecule
Molecular Formula:
C12H21N5
Molecular Weight:
235.34
AlogP:
0.67
PSA:
67.07
HBD:
2.0
HBA:
#RotB:
4.0
Source:
GC-4711
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GC-4711
×
Maximum Phase:
2
First Approval:
None
UNII:
FW5T90VM32
Molecule Type:
Small molecule
Molecular Formula:
C27H45MnN5O4
Molecular Weight:
558.63
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PCS-499
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Nephropathies; Renal Insufficiency, Chronic; Necrobiosis Lipoidica
Unknown
PCS-499
×
Maximum Phase:
2
First Approval:
None
UNII:
FLV771E8ZV
Molecule Type:
Small molecule
Molecular Formula:
C13H20N4O3
Molecular Weight:
285.36
AlogP:
-0.02
PSA:
82.05
HBD:
1.0
HBA:
#RotB:
5.0
Source:
HEMOGLOBIN GLUTAMER
2
Small molecule
Investigational
Unknown
Unknown
Coronary Disease; Peripheral Vascular Diseases
Unknown
HEMOGLOBIN GLUTAMER
×
Maximum Phase:
2
First Approval:
None
UNII:
1XQE66T19H
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PRATOSARTAN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Solute carrier family 22 member 12 inhibitor
PRATOSARTAN
×
Maximum Phase:
2
First Approval:
None
UNII:
66VLQ6E6DL
Molecule Type:
Small molecule
Molecular Formula:
C25H26N6O
Molecular Weight:
426.52
AlogP:
4.64
PSA:
89.35
HBD:
1.0
HBA:
#RotB:
6.0
Source:
A-002
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
A-002
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RADIPRODIL
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia; Spasms, Infantile
Glutamate NMDA receptor; GRIN1/GRIN2B antagonist
RADIPRODIL
×
Maximum Phase:
2
First Approval:
None
UNII:
5XGC17ZKUF
Molecule Type:
Small molecule
Molecular Formula:
C21H20FN3O4
Molecular Weight:
397.41
AlogP:
2.68
PSA:
95.41
HBD:
2.0
HBA:
#RotB:
3.0
Source:
CR 1447
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Androgen Receptor agonist
CR 1447
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIMETHYLAMINOETHANOL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIMETHYLAMINOETHANOL
×
Maximum Phase:
2
First Approval:
None
UNII:
2N6K9DRA24
Molecule Type:
Small molecule
Molecular Formula:
C4H11NO
Molecular Weight:
89.14
AlogP:
-0.46
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
2.0
Source:
KOS-1584
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Tubulin stabiliser
KOS-1584
×
Maximum Phase:
2
First Approval:
None
UNII:
82481G197K
Molecule Type:
Small molecule
Molecular Formula:
C27H39NO5S
Molecular Weight:
489.68
AlogP:
5.04
PSA:
96.72
HBD:
2.0
HBA:
#RotB:
2.0
Source:
L-SULFORAPHANE
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Unknown
L-SULFORAPHANE
×
Maximum Phase:
2
First Approval:
None
UNII:
7J94TPZ10L
Molecule Type:
Small molecule
Molecular Formula:
C6H11NOS2
Molecular Weight:
177.29
AlogP:
1.25
PSA:
29.43
HBD:
0.0
HBA:
#RotB:
5.0
Source:
APRICOXIB
2
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Pancreatic Neoplasms
Cyclooxygenase-2 inhibitor
APRICOXIB
×
Maximum Phase:
2
First Approval:
None
UNII:
5X5HB3VZ3Z
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O3S
Molecular Weight:
356.45
AlogP:
3.5
PSA:
74.32
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ALVELESTAT
2
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms; Severe Acute Respiratory Syndrome; Bronchiectasis; Cystic Fibrosis; Pulmonary Disease, Chronic Obstructive
Leukocyte elastase inhibitor
ALVELESTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
6Y5629322X
Molecule Type:
Small molecule
Molecular Formula:
C25H22F3N5O4S
Molecular Weight:
545.54
AlogP:
3.29
PSA:
115.95
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CP-724714
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasm Metastasis
Receptor protein-tyrosine kinase erbB-2 inhibitor
CP-724714
×
Maximum Phase:
2
First Approval:
None
UNII:
I05QZ0S4V3
Molecule Type:
Small molecule
Molecular Formula:
C27H27N5O3
Molecular Weight:
469.55
AlogP:
4.95
PSA:
98.26
HBD:
2.0
HBA:
#RotB:
9.0
Source:
ORNITHINE PHENYLACETATE
2
Small molecule
Investigational
Unknown
Unknown
Liver Cirrhosis; Liver Failure, Acute
Unknown
ORNITHINE PHENYLACETATE
×
Maximum Phase:
2
First Approval:
None
UNII:
9D6YZ105SN
Molecule Type:
Small molecule
Molecular Formula:
C13H20N2O4
Molecular Weight:
268.31
AlogP:
-0.86
PSA:
89.34
HBD:
3.0
HBA:
#RotB:
4.0
Source:
ERTEBEREL
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Hyperplasia; Schizophrenia
Estrogen receptor beta agonist
ERTEBEREL
×
Maximum Phase:
2
First Approval:
None
UNII:
2ZUL6758TZ
Molecule Type:
Small molecule
Molecular Formula:
C18H18O3
Molecular Weight:
282.34
AlogP:
4.12
PSA:
49.69
HBD:
2.0
HBA:
#RotB:
1.0
Source:
BCX-1777
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BCX-1777
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FENEBRUTINIB
2
Small molecule
Investigational
Unknown
Unknown
Autoimmune Diseases; Arthritis, Rheumatoid; Lupus Erythematosus, Systemic; Urticaria; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive
Tyrosine-protein kinase BTK inhibitor
FENEBRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
E9L2885WUL
Molecule Type:
Small molecule
Molecular Formula:
C37H44N8O4
Molecular Weight:
664.81
AlogP:
3.57
PSA:
120.99
HBD:
2.0
HBA:
#RotB:
7.0
Source:
RIVIPANSEL SODIUM
2
Small molecule
Investigational
Unknown
Unknown
Anemia, Sickle Cell
Unknown
RIVIPANSEL SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
11AEN6VWDN
Molecule Type:
Small molecule
Molecular Formula:
C58H70N6Na4O31S3
Molecular Weight:
1535.37
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SAR-125844
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
SAR-125844
×
Maximum Phase:
2
First Approval:
None
UNII:
XH93U6NIJE
Molecule Type:
Small molecule
Molecular Formula:
C25H23FN8O2S2
Molecular Weight:
550.65
AlogP:
4.15
PSA:
109.57
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PER977
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PER977
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POZANICLINE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Attention Deficit Disorder with Hyperactivity; Tobacco Use Disorder
Neuronal acetylcholine receptor; alpha6/beta2 partial agonist
POZANICLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
CL2002R563
Molecule Type:
Small molecule
Molecular Formula:
C11H16N2O
Molecular Weight:
192.26
AlogP:
1.52
PSA:
34.15
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PYRUVATE
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Glaucoma, Open-Angle
Unknown
PYRUVATE
×
Maximum Phase:
2
First Approval:
None
UNII:
8558G7RUTR
Molecule Type:
Small molecule
Molecular Formula:
C3H4O3
Molecular Weight:
88.06
AlogP:
-0.34
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
1.0
Source:
DNK333
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic; Irritable Bowel Syndrome
Neurokinin 1 receptor antagonist
DNK333
×
Maximum Phase:
2
First Approval:
None
UNII:
G9BL4978MZ
Molecule Type:
Small molecule
Molecular Formula:
C27H25Cl2F6N3O3
Molecular Weight:
624.41
AlogP:
6.06
PSA:
78.51
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PHOSPHOCREATINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PHOSPHOCREATINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACALISIB
2
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms
PI3-kinase p110-delta subunit inhibitor
ACALISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
OVW60IDW1D
Molecule Type:
Small molecule
Molecular Formula:
C21H16FN7O
Molecular Weight:
401.41
AlogP:
3.36
PSA:
101.38
HBD:
2.0
HBA:
#RotB:
4.0
Source:
DORAMAPIMOD
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Psoriasis
MAP kinase p38 alpha inhibitor
DORAMAPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
HO1A8B3YVV
Molecule Type:
Small molecule
Molecular Formula:
C31H37N5O3
Molecular Weight:
527.67
AlogP:
5.99
PSA:
80.65
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MERIMEPODIB
2
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Inosine-5'-monophosphate dehydrogenase 1 inhibitor
MERIMEPODIB
×
Maximum Phase:
2
First Approval:
None
UNII:
2ZL2BA06FU
Molecule Type:
Small molecule
Molecular Formula:
C23H24N4O6
Molecular Weight:
452.47
AlogP:
4.01
PSA:
123.95
HBD:
3.0
HBA:
#RotB:
7.0
Source:
FGF401
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Neoplasms
Fibroblast growth factor receptor 4 inhibitor
FGF401
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H30N8O4
Molecular Weight:
506.57
AlogP:
1.48
PSA:
143.79
HBD:
2.0
HBA:
#RotB:
8.0
Source:
Z160
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia, Postherpetic; Radiculopathy
Voltage-gated N-type calcium channel alpha-1B subunit blocker
Z160
×
Maximum Phase:
2
First Approval:
None
UNII:
TX3R141LEP
Molecule Type:
Small molecule
Molecular Formula:
C32H32N2O
Molecular Weight:
460.62
AlogP:
6.14
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
7.0
Source:
1
2
…
101
102
103
104
105
106
107
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA